文献速递关节外科

全膝关节置换术中最小临床重要差异存在显著不一致性:一项系统综述

There are Considerable Inconsistencies Among Minimum Clinically Important Differences in TKA: A Systematic Review.
PubMed 文献 · Clin Orthop Relat Res · 2022-10-05

该研究遵循PRISMA指南,系统检索PubMed、EMBASE和MEDLINE数据库至2022年3月,纳入38篇报告全膝关节置换术后患者报告结局测量工具最小临床重要差异(MCID)值的文章,共涉及710,128例患者,中位年龄67.7岁。研究分析了49种独特PROM的233个MCID值,发现WOMAC功能和疼痛子评分报告最频繁,且大多数PROM的中位MCID值在不同计算方法间无差异。作者建议牛津膝关节评分(OKS)的MCID采用7分增加,复合WOMAC采用10-15分增加。

要点

  • WOMAC功能与疼痛子评分各报告22/233个MCID值(9%),OKS报告21/233个(9%)。
  • 39%(15/38)研究采用锚定法,32%(12/38)采用分布法,29%(11/38)同时使用两种方法计算MCID。
  • 除WOMAC功能子评分和KOOS疼痛与日常生活活动子评分外,其余PROM的中位MCID值不受计算方法影响(p>0.05)。

核心结论

  • 尽管各PROM的MCID值存在变异性,但已发表研究中MCID的推导方法具有一致性,且多数评估的PROM在不同计算方法间MCID值存在共识。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索PubMed、EMBASE和MEDLINE数据库从建库至2022年3月,纳入38篇计算初次全膝关节置换术后PROM的MCID值的文章,共710,128例患者,中位年龄67.7岁,中位BMI 30.9 kg/m²,中位随访17个月(范围0.25至72个月)。

主要发现

  • WOMAC功能子评分锚定法中位MCID为23(IQR 16至33),分布法为11(IQR 10.8至11);疼痛子评分锚定法为25(IQR 14至31),分布法为22(IQR 17至23)。
  • OKS锚定法中位MCID为6(IQR 4至7),分布法为7(IQR 5至10)。
  • 锚定法研究中最常用锚点为五点Likert量表评估满意度、疼痛缓解或生活质量(40% [16/40]),其次为ROC曲线估计(25% [10/40])。
  • 分布法研究中所有文章均使用研究人群方差,最常用方法为术前术后PROM评分差值的标准差的一半(45% [14/31])。
  • 大多数PROM(15/19)的中位MCID值在不同计算方法间无差异(p>0.05),例外为WOMAC功能子评分和KOOS疼痛与日常生活活动子评分。

关键数值与推荐

  • WOMAC功能子评分中位MCID:锚定法23(IQR 16至33),分布法11(IQR 10.8至11)。
  • WOMAC疼痛子评分中位MCID:锚定法25(IQR 14至31),分布法22(IQR 17至23)。
  • OKS中位MCID:锚定法6(IQR 4至7),分布法7(IQR 5至10)。
  • 复合WOMAC中位MCID为12(IQR 10至17),计算方法间无差异。

临床怎么用

  • 作者推荐使用7分增加作为OKS的MCID,与来自多项高质量大样本研究采用锚定法得出的中位值一致。
  • 作者推荐使用10分至15分增加作为复合WOMAC的MCID,其中位值为12(IQR 10至17)且计算方法间无差异。
  • 作者推荐WOMAC功能子评分和疼痛子评分分别使用中位报告值21(IQR 15至33)和23(IQR 13至29)。

局限性

  • 总体偏倚风险采用Jadad标准评估一项随机对照试验为3分(满分5分),采用改良MINORS标准评估比较性研究平均17.2±1.8分、非比较性研究平均9.6±1.3分,总体评为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-reported outcome measures (PROMs) are frequently used to assess the impact of total knee arthroplasty (TKA) on patients. However, mere statistical comparison of PROMs is not sufficient to assess the value of TKA to the patient, especially given the risk profile of arthroplasty. Evaluation of treatment effect sizes is important to support the use of an intervention; this is often quantified with the minimum clinically important difference (MCID). MCIDs are unique to specific PROMs, as they vary by calculation methodology and study population. Therefore, a systematic review of calculated MCID values, their respective ranges, and assessment of their applications is important to guide and encourage their use as a critical measure of effect size in TKA outcomes research. QUESTIONS/PURPOSES: In this systematic review of MCID calculations and reporting in primary TKA, we asked: (1) What are the most frequently reported PROM MCIDs and their reported ranges in TKA? (2) What proportion of studies report distribution- versus anchor-based MCID values? (3) What are the most common methods by which these MCID values are derived for anchor-based values? (4) What are the most common derivation methods for distribution-based values? (5) How do the reported medians and corresponding interquartile ranges (IQR) compare between calculation methods for each PROM? METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review was conducted using the PubMed, EMBASE, and MEDLINE databases from inception through March 2022 for TKA articles reporting an MCID value for any PROMs. Two independent reviewers screened articles for eligibility, including any article that calculated new MCID values for PROMs after primary TKA, and extracted these data for analysis. Overall, 576 articles were identified, 38 of which were included in the final analysis. These studies had a total of 710,128 patients with a median age of 67.7 years and median BMI of 30.9 kg/m 2 . Women made up more than 50% of patients in most studies, and the median follow-up period was 17 months (range 0.25 to 72 months). The overall risk of bias was assessed as moderate using the Jadad criteria for one randomized controlled trial (3 of 5 ideal global score) and the modified Methodological Index for Non-randomized Studies criteria for comparative studies (mean 17.2 ± 1.8) and noncomparative studies (mean 9.6 ± 1.3). There were 49 unique PROMs for which 233 MCIDs were reported. Calculated values were classified as anchor-based, distribution-based, or not reported. MCID values for each PROM, MCID calculation method, number of patients, and study demographics were extracted from each study. Anchor-based and distribution-based MCIDs were compared for each unique PROM using a Wilcoxon rank sum test given non-normal distribution of values. RESULTS: The WOMAC Function and Pain subscores were the most frequently reported MCID value, comprising 9% (22 of 233) and 9% (22 of 233), respectively. The composite Oxford Knee Score (OKS) was the next most frequently reported (9% [21 of 233]), followed by the WOMAC composite score (6% [13 of 233]). The median anchor-based values for WOMAC Function and Pain subscores were 23 (IQR 16 to 33) and 25 (IQR 14 to 31), while the median distribution-based values were 11 (IQR 10.8 to 11) and 22 (IQR 17 to 23), respectively. The median anchor-based MCID value for the OKS was 6 (IQR 4 to 7), while the distribution-based value was 7 (IQR 5 to 10). Thirty-nine percent (15 of 38) used an anchor-based method to calculate a new MCID, while 32% (12 of 38) used a distribution-based technique. Twenty-nine percent of studies (11 of 38) calculated MCID values using both methods. For studies reporting an anchor-based calculation method, a question assessing patient satisfaction, pain relief, or quality of life along a five-point Likert scale was the most commonly used anchor (40% [16 of 40]), followed by a receiver operating characteristic curve estimation (25% [10 of 40]). For studies using distribution-based calculations, all articles used a measure of study population variance in their derivation of the MCID, with the most common method reported as one-half the standard deviation of the difference between preoperative and postoperative PROM scores (45% [14 of 31]). Most reported median MCID values (15 of 19) did not differ by calculation method for each unique PROM (p > 0.05) apart from the WOMAC Function component score and the Knee Injury and Osteoarthritis Outcome Score Pain and Activities of Daily Living subscores. CONCLUSION: Despite variability of MCIDs for each PROM, there is consistency in the methodology by which MCID values have been derived in published studies. Additionally, there is a consensus about MCID values regardless of calculation method across most of the PROMs we evaluated. CLINICAL RELEVANCE: Given their importance to treatment selection and patient safety, authors and journals should report MCID values with greater consistency. We recommend using a 7-point increase as the MCID for the OKS, consistent with the median reported anchor-based value derived from several high-quality studies with large patient groups that used anchor-based approaches for MCID calculation, which we believe are most appropriate for most applications in clinical research. Likewise, we recommend using a 10-point to 15-point increase for the MCID of composite WOMAC, as the median value was 12 (IQR 10 to 17) with no difference between calculation methods. We recommend use of median reported values for WOMAC function and pain subscores: 21 (IQR 15 to 33) and 23 (IQR 13 to 29), respectively.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Deckey DG, Verhey JT, Gerhart CRB, et al. There are Considerable Inconsistencies Among Minimum Clinically Important Differences in TKA: A Systematic Review. Clin Orthop Relat Res. 2022. PMID: 36200846. doi:10.1097/CORR.0000000000002440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。